securities class action

Snowflake Inc. faces securities class action lawsuit alleging false statements about product efficiency and features. Lead plaintiff deadline set for April 27, 2026.

REGENXBIO faces securities lawsuit over alleged misleading RGX-111 gene therapy statements. Lead plaintiff deadline is April 14, 2026.

Rosen Law Firm urges $BBWI investors to join class action by March 16, 2026 deadline, alleging materially false statements about business strategy and unmet financial guidance.

Rosen Law Firm solicits Beyond Meat investors from Feb-Nov 2025 for class action alleging material asset value misstatements and impairment disclosure failures.

BellRing Brands faces securities lawsuit alleging it misrepresented sales growth as organic when driven by inventory stockpiling, with a March 23, 2026 deadline for investors to join.

Rosen Law Firm alerts $SNOW investors of April 27, 2026 deadline in class action alleging undisclosed negative impacts from product efficiency gains.

uniQure faces securities lawsuit after FDA rejected AMT-130 approval pathway. Stock plummeted 49% following disclosure. Lead plaintiff deadline: April 13, 2026.

Apollo Global Management faces class action over alleged Epstein executive communications non-disclosure. Investors with $100,000+ losses must apply as lead plaintiffs by May 1, 2026.

Rosen Law Firm sued Richtech Robotics for allegedly misrepresenting a Microsoft partnership. Investors must file claims by April 3, 2026.

Rosen Law Firm notifies $CORT investors of securities class action alleging misrepresentation of clinical trial data for relacorilant drug and undisclosed FDA concerns.

Rosen Law Firm files securities class action against Franklin BSP Realty Trust alleging false statements. Investors must act before lead plaintiff deadline.

Rosen Law Firm urges Endeavor Group Holdings investors to secure counsel before March 18 deadline in securities class action over alleged false SEC filings.

Rosen Law Firm reminds $PSFE investors of April 7, 2026 deadline in securities lawsuit alleging false statements on ecommerce exposure and credit reserves.

Corcept Therapeutics faces securities class action over allegedly misleading statements about relacorilant's FDA approval prospects, triggering 50% stock plunge and $3.6B market cap loss.

PayPal faces class action lawsuit after Q4 earnings disappointed, stock plunged 20%, erasing $9B in market value. CEO departed.

Rosen Law Firm sued $ENPH for allegedly misleading investors on inventory management and financial prospects amid tax credit concerns.

Rosen Law Firm sues Nektar Therapeutics for alleged false statements about clinical trial protocols, seeking damages for injured investors as litigation moves forward.

DNOW Inc. shares crashed 19.1% after disappointing Q4 2025 results. The Rosen Law Firm is investigating potential securities violations for investor compensation.

Driven Brands faces securities lawsuit after revealing material accounting errors spanning 2023-2024. Stock crashed 40% to $9.99 on disclosure of internal control failures.

Rosen Law Firm alerts $POM investors of April 7, 2026 lead plaintiff deadline in securities fraud lawsuit alleging false statements and manipulative trading schemes.